Fracture Prediction by Opportunistic Screening for Osteoporosis
NCT ID: NCT03570177
Last Updated: 2024-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
173720 participants
OBSERVATIONAL
2018-10-01
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improved Screening for Osteoporosis
NCT02066480
Opportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung Disease
NCT05714787
Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort
NCT02606162
General Practitioner's Place in the Treatment of Fracture Osteoporosis in the Elderly
NCT03402958
Incidence of Fragility Fractures and Osteoporosis Screening in Chronic Stroke Patients
NCT06804252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objective :
* Assessment of the performance of an automatic measurement of lumbar vertebral bone density on routine abdominal scans (performed for other medical indications) for the prediction of fractures (necessitating hospitalization) over 3 years according to the location of fracture (spine, hip, non- spine-non-hip).
* Assessment of the performance of an automatic measurement of lumbar vertebral bone density on routine abdominal scans (performed for other medical indications) for the prediction of fractures (necessitating hospitalization) over 3 years according to age (\>= 75 vs \< 75) and sex.
* Assessment of the impact of a preventive treatment of patients at high risk of fracture in terms of number of avoided fractures (simulation study)
* Assessment of classical risk factors of fracture (using SNDS database) and added value of the automatic bone density measurement on fracture risk estimation.
* Prevalence estimation of vertebral fractures (as assessed automatically by the Zebra algorithm) in the population at index date
* Assessment of the impact of IV contrast on the values of the measurements provided by the Zebra algorithm.
* To establish mean values for zebra parameters according to age and gender in subjects without fracture.
The study is based on the patients of the Paris University Hospitals / Assistance Publique - Hôpitaux de Paris (AP-HP), the largest hospital entity in Europe, who had, whatever the medical indication, an abdominal CT; the CT related data (metadata and data issued from the analysis of abdominal CT with the Zebra software) and images are stored in the PACS workstation (available since 2007), and are available through the AP-HP Clinical Data Repository (CDR). After legal authorizations, data from the CDR will be merged with data from the national Programme de Médicalisation des Systèmes d'Information (PMSI) database within the national system of health data SNDS (Système National des Données de Santé), which records all discharge summaries of public and private hospitals in France (i.e. the national PMSI (Programme de Médicalisation des Systèmes d'Information) database) and reimbursed outpatient care (i.e. the DCIR database).
Each summary of the PMSI contains the age and sex of the patient, the motive of admission, described through the diagnosis codes from the International Statistical Classification of Diseases, 10th Revision (ICD-10) and secondary diagnosis, allowing to identify fractures and, among them, neoplastic (on bone metastasis or primary bone cancer) will not be considered as event of interest.
* All legible abdominal scans performed between 2007 and 2014 at AP-HP in subjects of 60 years and older (i.e. those at a priori higher risk of fragility fractures) during a hospital stay and stored on PACS workstation will be used. If a subject performed several abdominal scans, only the first one will be used.
* Vertebral BMD will be calculated automatically with a validated algorithm (in Hounsfield Unit - HU), with the lower attenuation (lower HU) representing less dense bone (i.e. more fragile), at each vertebra from L1 to L4. The algorithm automatically segments the L1-L4 vertebrae, and extracts their overall density based on a number of features extracted. The analysis of abdominal CT with the Zebra software will also identify vertebral fractures.
* Clinical data of APHP patients are available in the CDR.
* Incident fractures will be identified in the national PMSI database within the SNDS (2007-2017). An event will be defined by the occurrence of an incident fracture (excluding polytraumatic fractures and neoplastic fractures) necessitating hospitalization, within 3 years after the abdominal scan.
* Prediction of the occurrence of incident fracture (as defined above) by vertebral BMD will be assessed.
The source population will be patients 60 years and older (i.e. those at a priori higher risk of fragility fractures because of age) who had abdominal QCT with images stored centrally in the Picture Archiving and Communication System (PACS) of our institution (Assistance Publique Hôpitaux de Paris, AP-HP). AP-HP is the largest university hospital entity in Europe (Greater Paris University Hospitals, 39 hospitals, 23 of which are for acute care, 20,700 beds including 11700 beds for acute care, more than 7 million patients treated and 1.2 million hospitalizations each year in acute care). The PACS has been implemented in 2007, and stores all the images acquired in the AP-HP institution and related data. These data are available in the CDR.
After legal authorizations, data from the CDR will be merged with data from the SNDS (Système National des Données de Santé) which includes data from the national Programme de Médicalisation des Systèmes d'Information (PMSI).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
all subject
the all population (described in eligibility criteria)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having an abdominal scan\* in the PACS workstation, whatever the medical indication (Axial or Sagittal slices / Slice thickness of 4mm or better / Presence of the L1 to L4 vertebrae) made during a hospitalization in an APHP hospital between 2007 and 2014.
We will use the term abdominal scan for any scan involving L1 to L4 vertebrae, i.e. abdominal scans, thoraco-abdominal scans, lombar scans…
Exclusion Criteria
* Impossibility to match the CT scan data with the SNDS (including the French Hospital National Database (Programme de Médicalisation des Systèmes d'Information: PMSI)\*, which includes all hospitalizations occurring in public and private acute care settings in France), between 2007 and 2017. Matching will be performed using probabilistic matching, as described below. It will give incident fracture data during follow-up.
* Foreign resident
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian ROUX, Pr
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Sofia ZEMOURI
Role: STUDY_CHAIR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
La Pitié Salpétrière Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOM16095
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.